ABOUT
US
KNOWLEDGE IS POWER
We believe in informed decision-making, especially regarding women’s health.
Breast density is common and normal, but current measurement and classification methods are lengthy and inaccessible to young women. We strive to change this. We have developed a new breast tissue analysis method that quickly and safely provides breast density data pre-imaging, enabling personalised imaging and instant risk assessment for all women.
Our device was originally based on technology developed for the detection of non-ferrous landmines. Starting as a PhD project at the University of Bristol, researchers realised the potential for the technology in breast cancer detection. Micrima has been dedicated to the technology for almost 20 years, recently pivoting to our new product for the measurement of breast tissue properties.
We are a diverse team of engineers, software developers, healthcare professionals and much more with expertise in clinical, scientific, technology and innovation fields. Supported by Innovate UK, we are currently focused on trialling our technology in clinic.
Meet The Team
-
![]()
Adrian Waller
CHIEF EXECUTIVE OFFICER
-
![]()
Leigh Cornock
CHIEF TECHNICAL OFFICER
-
Emma Jackson
CLINICAL AFFAIRS MANAGER
-
![]()
Nick Randall
CHAIRMAN
-
Dr Nisha Sharma
CHAIR OF OUR CLINICAL ADVISORY BOARD
Learn more
-
Our Tech.
Breast tissue analysis with radio frequency and AI. Instant results in our custom software with breast cancer risk calculator integration.
-
Breast Density.
Breast density can obscure cancer on a mammogram. Breast cancer risk increases as density increases. Learn more below.
-
Mi~Story.
Numbers are important, but each story counts. Read about the experiences of women with breast cancer and dense breasts.